Patients with coronary heart disease (CHD) who received selective serotonin reuptake inhibitors (SSRIs) for six weeks had a lower rate of mental stress-induced myocardial ischemia compared with those who took placebos, according to results of the REMIT trial published May 22 in the Journal of the American Medical Association.